Cargando...
Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
Anemia is a major complication of chronic kidney disease (CKD), which mainly results from appropriate erythropoietin production impairment. Prolyl hydroxylase domain (PHD) inhibitors are currently being developed and approved in some countries as a new treatment for CKD patients with anemia due to t...
Gardado en:
| Publicado en: | Ther Clin Risk Manag |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7898206/ https://ncbi.nlm.nih.gov/pubmed/33628028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S293879 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|